EMT and MET in carcinoma--clinical observations, regulatory pathways and new models - PubMed (original) (raw)

EMT and MET in carcinoma--clinical observations, regulatory pathways and new models

Erik W Thompson et al. Clin Exp Metastasis. 2008.

Abstract

EMT and MET in carcinoma-clinical observations, regulatory pathways and new models.

PubMed Disclaimer

Similar articles

• The role of epithelial-mesenchymal transition in cancer pathology.
  Guarino M, Rubino B, Ballabio G. Guarino M, et al. Pathology. 2007 Jun;39(3):305-18. doi: 10.1080/00313020701329914. Pathology. 2007. PMID: 17558857 Review.
• Epithelial-mesenchymal transition in ovarian cancer progression: a crucial role for the endothelin axis.
  Bagnato A, Rosanò L. Bagnato A, et al. Cells Tissues Organs. 2007;185(1-3):85-94. doi: 10.1159/000101307. Cells Tissues Organs. 2007. PMID: 17587812 Review.
• [Epithelial-mesenchymal transitions in cancer onset and progression].
  Thiery JP. Thiery JP. Bull Acad Natl Med. 2009 Dec;193(9):1969-78; discussion 1978-9. Bull Acad Natl Med. 2009. PMID: 20666011 French.
• lncRNA HOTAIR overexpression induced downregulation of c-Met signaling promotes hybrid epithelial/mesenchymal phenotype in hepatocellular carcinoma cells.
  Topel H, Bagirsakci E, Comez D, Bagci G, Cakan-Akdogan G, Atabey N. Topel H, et al. Cell Commun Signal. 2020 Jul 11;18(1):110. doi: 10.1186/s12964-020-00602-0. Cell Commun Signal. 2020. PMID: 32650779 Free PMC article.

Cited by

• Interplay between PCBP2 and miRNA modulates ARHGDIA expression and function in glioma migration and invasion.
  Lin X, Yang B, Liu W, Tan X, Wu F, Hu P, Jiang T, Bao Z, Yuan J, Qiang B, Peng X, Han W. Lin X, et al. Oncotarget. 2016 Apr 12;7(15):19483-98. doi: 10.18632/oncotarget.6869. Oncotarget. 2016. PMID: 26761212 Free PMC article.
• Epithelial mesenchymal transition in drug resistance and metastasis of lung cancer.
  Nurwidya F, Takahashi F, Murakami A, Takahashi K. Nurwidya F, et al. Cancer Res Treat. 2012 Sep;44(3):151-6. doi: 10.4143/crt.2012.44.3.151. Epub 2012 Sep 30. Cancer Res Treat. 2012. PMID: 23091440 Free PMC article.
• Upregulation of SATB1 is associated with prostate cancer aggressiveness and disease progression.
  Shukla S, Sharma H, Abbas A, MacLennan GT, Fu P, Danielpour D, Gupta S. Shukla S, et al. PLoS One. 2013;8(1):e53527. doi: 10.1371/journal.pone.0053527. Epub 2013 Jan 7. PLoS One. 2013. PMID: 23308245 Free PMC article.
• Androgen-targeted therapy-induced epithelial mesenchymal plasticity and neuroendocrine transdifferentiation in prostate cancer: an opportunity for intervention.
  Nouri M, Ratther E, Stylianou N, Nelson CC, Hollier BG, Williams ED. Nouri M, et al. Front Oncol. 2014 Dec 23;4:370. doi: 10.3389/fonc.2014.00370. eCollection 2014. Front Oncol. 2014. PMID: 25566507 Free PMC article. Review.
• Secretomic analysis identifies alpha-1 antitrypsin (A1AT) as a required protein in cancer cell migration, invasion, and pericellular fibronectin assembly for facilitating lung colonization of lung adenocarcinoma cells.
  Chang YH, Lee SH, Liao IC, Huang SH, Cheng HC, Liao PC. Chang YH, et al. Mol Cell Proteomics. 2012 Nov;11(11):1320-39. doi: 10.1074/mcp.M112.017384. Epub 2012 Aug 15. Mol Cell Proteomics. 2012. PMID: 22896658 Free PMC article.

References

1. 1. Cell. 2008 May 16;133(4):704-15 - PubMed
2. 1. J Natl Cancer Inst. 2008 May 7;100(9):672-9 - PubMed
3. 1. Differentiation. 2007 Nov;75(9):831-42 - PubMed
4. 1. Methods Mol Biol. 2007;374:135-45 - PubMed
5. 1. Cancer Res. 2005 Jul 15;65(14):5996-6000; discussion 6000-1 - PubMed

Publication types

MeSH terms

LinkOut - more resources

• Full Text Sources

  • Ovid Technologies, Inc.
  • Springer

• Miscellaneous

  • NCI CPTAC Assay Portal